Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Ulisciani

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Cancer Letters|July 26, 2008
Imatinib resistance in CMLGisella Volpe, Cristina Panuzzo, Stefano Ulisciani, et al.
Current Hematologic Malignancy Reports|April 29, 2010
Molecular monitoring in patients with chronic myelogenous leukemiaGiuseppe Saglio, Stefano Ulisciani, Milena Fava, et al.
Leukemia & Lymphoma|April 10, 2008
New therapeutic approaches and prognostic factors in chronic myeloid leukemiaGiuseppe Saglio, Stefano Ulisciani, Marco Bosa, et al.
Multidisciplinary Respiratory Medicine|September 11, 2012
JAK2 V617F mutation negative erythrocytosis (or how to more simply perform diagnosis and treat a patient with increased hematocrit)Luca Zito, Roberto Torchio, Kassem Bannout, et al.
World Journal of Radiology|August 30, 2014
Pathophysiology, clinical features and radiological findings of differentiation syndrome/all-trans-retinoic acid syndromeLuciano Cardinale, Francesco Asteggiano, Federica Moretti, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 29, 2026
Long-term outcomes of autologous haematopoietic stem cell transplantation in multiple sclerosis: A retrospective single-centre experienceSimona Malucchi, Marco De Gobbi, Maria Malentacchi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 10, 2008
Acute myeloid leukemia induced by mitoxantrone treatment for aggressive multiple sclerosisMarco Capobianco, Simona Malucchi, Stefano Ulisciani, et al.
Journal of Chromatographic Science|November 15, 2011
A new HPLC-UV validated method for therapeutic drug monitoring of tyrosine kinase inhibitors in leukemic patientsElisa Pirro, Silvia De Francia, Francesca De Martino, et al.
Biomarker Research|July 7, 2015
Detection of BCR-ABL T315I mutation by peptide nucleic acid directed PCR clamping and by peptide nucleic acid FISHValentina Rosso, Enrico Bracco, Roberto Pedrola, et al.
Leukemia Research|June 28, 2011
Dasatinib is safe and effective in unselected chronic myeloid leukaemia elderly patients resistant/intolerant to imatinibRoberto Latagliata, Massimo Breccia, Fausto Castagnetti, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cancer Letters|July 26, 2008
Imatinib resistance in CMLGisella Volpe, Cristina Panuzzo, Stefano Ulisciani, et al.
Current Hematologic Malignancy Reports|April 29, 2010
Molecular monitoring in patients with chronic myelogenous leukemiaGiuseppe Saglio, Stefano Ulisciani, Milena Fava, et al.
Leukemia & Lymphoma|April 10, 2008
New therapeutic approaches and prognostic factors in chronic myeloid leukemiaGiuseppe Saglio, Stefano Ulisciani, Marco Bosa, et al.
Multidisciplinary Respiratory Medicine|September 11, 2012
JAK2 V617F mutation negative erythrocytosis (or how to more simply perform diagnosis and treat a patient with increased hematocrit)Luca Zito, Roberto Torchio, Kassem Bannout, et al.
World Journal of Radiology|August 30, 2014
Pathophysiology, clinical features and radiological findings of differentiation syndrome/all-trans-retinoic acid syndromeLuciano Cardinale, Francesco Asteggiano, Federica Moretti, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 29, 2026
Long-term outcomes of autologous haematopoietic stem cell transplantation in multiple sclerosis: A retrospective single-centre experienceSimona Malucchi, Marco De Gobbi, Maria Malentacchi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 10, 2008
Acute myeloid leukemia induced by mitoxantrone treatment for aggressive multiple sclerosisMarco Capobianco, Simona Malucchi, Stefano Ulisciani, et al.
Journal of Chromatographic Science|November 15, 2011
A new HPLC-UV validated method for therapeutic drug monitoring of tyrosine kinase inhibitors in leukemic patientsElisa Pirro, Silvia De Francia, Francesca De Martino, et al.
Biomarker Research|July 7, 2015
Detection of BCR-ABL T315I mutation by peptide nucleic acid directed PCR clamping and by peptide nucleic acid FISHValentina Rosso, Enrico Bracco, Roberto Pedrola, et al.
Leukemia Research|June 28, 2011
Dasatinib is safe and effective in unselected chronic myeloid leukaemia elderly patients resistant/intolerant to imatinibRoberto Latagliata, Massimo Breccia, Fausto Castagnetti, et al.
Pageof 2